Full-Time

District Business Manager

Posted on 1/23/2025

Azurity Pharmaceuticals

Azurity Pharmaceuticals

201-500 employees

Develops specialized formulations of medicines

No salary listed

Mid, Senior

United States

Hybrid work model: 2 days from home and 3 days in the office.

Category
Field Sales
Sales & Account Management
Required Skills
Data Analysis
Requirements
  • BA or BS degree (MBA or advanced degree a plus)
  • 3+ years of progressive experience in specialty pharmaceutical sales, including field sales management and product launch experience as a representative and sales leader
  • Expertise in customer-facing organization sales strategy and optimization efforts within multi-channel customers, with strong pharmacy-related success
  • Strong leadership, team building and organizational skills. Proven ability to coach and develop sales professionals as well as technical ability to coordinate functional business activities
  • Strong strategic and analytical skills with the ability to translate business goals into specific objectives - experience utilizing secondary data: syndicated sales data by customer channel, longitudinal patient-level data, and payer-level data
  • Strong communication skills and ability to influence and align at all levels of the organization
  • Must be effective working in a team environment with strong collaboration skills to gain alignment
  • Must be able to work in a fast-paced and results-oriented environment with the ability to handle multiple product launches across a myriad of therapeutic areas
  • Strong understanding of pharmaceutical regulatory/legal environment with knowledge of compliance requirements for appropriate interactions and relationships with healthcare professionals (i.e., PhRMA Code)
  • Strong understanding of the Retail and Institutional Marketplace
  • Knowledge of various CRM call reporting and dashboard systems
  • Extensive proficiency with Microsoft Office (Word, Excel, PowerPoint, Teams, and Outlook)
  • Travel requirement: Approximately 75% including overnight stays
Responsibilities
  • Provide direct management, coaching, and leadership to a District of Therapeutic Sales Specialist (sales representatives)
  • Develop and implement business plans for assigned districts and assist individual TSS operating in the next-gen way of working using a next-best action engine
  • Execute overall strategy and direction for the Pediatric Medicine Franchise
  • Work closely with Commercial Operations to optimize field force alignment to ensure success in an ever-changing environment due to external market dynamics
  • Drive new creative ideation and execution regarding customer engagements leveraging innovative techniques via virtual and face-to-face selling opportunities
  • Build and develop a high-performing and diverse team by attracting, selecting, developing, and retaining talented individuals who share the goals and vision of the organization
  • Embrace entrepreneurial spirit for an emerging biopharmaceutical company - the ability to foster relationships and the ability to develop innovative ideas and solutions
  • Ensure product strategies and messages are being fully communicated and executed according to plan
  • Execute a new, novel approach and implementation of objective analysis to support customer relationship management (CRM) and engagement via the Azurity Commercial Excellence (ACE) platform leveraging vital components including sales force strategy and analysis, targeting, optimal territory alignment, reporting requirements and sales force incentive plans
  • Execute strategies to increase sales routing and overall efficiency
  • Partner in the execution of all training needed to ensure high-level product knowledge and selling skills, plus proficiency in systems and processes to ensure accuracy in reporting metrics
  • Provide strong leadership and direction to maximize business opportunities and work collaboratively with other key functions to address customer needs
  • Partner with HR to implement recruitment strategies, as well as employee development and performance management plans
  • Use internal and external resources to collect and analyze various data sources to make sound business decisions
Desired Qualifications
  • MBA or advanced degree a plus
Azurity Pharmaceuticals

Azurity Pharmaceuticals

View

Azurity Pharmaceuticals develops specialized formulations of established medicines to meet the needs of patients often overlooked by other pharmaceutical companies. Their products include oral suspensions and other dose forms that are easier to administer, particularly for those who have difficulty swallowing pills or need precise dosing. This focus on creating accessible and effective medications enhances patient compliance and addresses gaps in the pharmaceutical market. Azurity serves healthcare providers, hospitals, and pharmacies, generating revenue through the sale of FDA-approved proprietary medicines across various therapeutic areas, including cardiovascular, central nervous system, and oncology. Their goal is to improve patient outcomes by providing high-quality, innovative medicines tailored to specific medical conditions.

Company Size

201-500

Company Stage

Growth Equity (Venture Capital)

Total Funding

$182.2M

Headquarters

Woburn, Massachusetts

Founded

2000

Simplify Jobs

Simplify's Take

What believers are saying

  • Growing demand for personalized medicine aligns with Azurity's specialized dose forms.
  • Increasing chronic diseases boost need for Azurity's innovative drug delivery systems.
  • FDA's focus on novel formulations benefits Azurity's product pipeline.

What critics are saying

  • Product recalls, like Zenzedi's, can damage brand reputation and cause financial losses.
  • Integration challenges from Slayback Pharma acquisition may disrupt operations.
  • Reliance on FDA approvals means regulatory delays could impact product launches.

What makes Azurity Pharmaceuticals unique

  • Azurity focuses on innovative dose forms for overlooked patient needs.
  • Their FDA-approved products ensure safety and efficacy in specialized formulations.
  • Azurity's acquisition of Slayback Pharma enhances its development and launch capabilities.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Health Insurance

Dental Insurance

Vision Insurance

401(k) Company Match

401(k) Retirement Plan

Paid Vacation

Paid Holidays

Hybrid Work Options

Professional Development Budget

Tuition Reimbursement

Wellness Program

Company News

PR Newswire
Dec 12th, 2024
Azurity Pharmaceuticals, Inc. Announces Availability Of Azmiro™ (Testosterone Cypionate) Injection For Intramuscular Use, Ciii

WOBURN, Mass., Dec. 12, 2024 /PRNewswire/ -- Azurity Pharmaceuticals announced today the availability of Azmiro™, the first and only FDA-approved prefilled testosterone cypionate injection. Azmiro is an androgen indicated for testosterone replacement therapy in males for conditions associated with a deficiency or absence of endogenous testosterone. "Azurity's purpose is to serve overlooked patients by developing innovative dose forms and formulations to serve unmet needs," said Richard Blackburn, CEO of Azurity Pharmaceuticals. "The commercial availability of Azmiro offers a convenient prefilled option for healthcare providers administering testosterone to patients.". Testosterone cypionate intramuscular injections are commonly used as a testosterone replacement therapy for patients with low testosterone by drawing up testosterone cypionate doses from a vial, then administering with a syringe

Eastern Progress
Dec 12th, 2024
AZURITY PHARMACEUTICALS, INC. ANNOUNCES AVAILABILITY OF AZMIRO(TM) (testosterone cypionate) injection for intramuscular use, CIII

WOBURN, Mass., Dec. 12, 2024 /PRNewswire/ - Azurity Pharmaceuticals announced today the availability of Azmiro(TM), the first and only FDA-approved prefilled testosterone cypionate injection.

PR Newswire
May 6th, 2024
Azurity Pharmaceuticals, Inc. Announces Fda Approval Of Myhibbin™ (Mycophenolate Mofetil Oral Suspension)

WOBURN, Mass., May 6, 2024 /PRNewswire/ -- Azurity Pharmaceuticals, a pharmaceutical company focused on developing innovative dose forms and formulations of products to serve the needs of overlooked patients, announced today that the U.S. Food and Drug Administration (FDA) has approved Myhibbin™, the only ready-to-use mycophenolate mofetil oral suspension. Mycophenolate mofetil is an antimetabolite immunosuppressant used to protect a donated organ from being rejected from the body's immune response. In 2023, there were over 46,000 transplants in the US and these patients need to take medication every day to fight against rejection. Myhibbin is indicated for the prophylaxis of organ rejection in adult and pediatric recipients 3 months of age and older of allogeneic kidney, heart, or liver transplants, in combination with other immunosuppressants."We are very pleased that adult and pediatric organ transplant recipients will soon have access to the only FDA-approved ready-to-use oral liquid formulation of mycophenolate," said Richard Blackburn, CEO of Azurity Pharmaceuticals. "Patients are our priority, and our purpose is to bring them new formulations that help them benefit from established medicines

AJMC
Jan 30th, 2024
What We're Reading: ADHD Medication Mix-Up; Surge in ACOs; Mifepristone Restrictions

Azurity Pharmaceuticals issued a recall for attention-deficit/hyperactivity disorder (ADHD) medication dextroamphetamine sulfate (Zenzedi) following the discovery of a potential mix-up in pill packaging, according to CNN.

Newsweek
Jan 26th, 2024
ADHD Drug Recall as Mislabeled Package Sparks Warning

Azurity Pharmaceuticals, Inc. announced the recall of one lot (F230169A) of Zenzedi CII (dextroamphetamine sulfate tablets, USP) 30 milligrams on Wednesday, which the U.S. Food and Drug Administration (FDA) put on its website on Thursday.

INACTIVE